Correction to: Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
Blair, Hannah A.
Drugs & therapy perspectives : for rational drug selection and use, 2024, Vol.40 (4), p.172-172 [Periódico revisado por pares]Cham: Springer International Publishing
Texto completo disponível